Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
“The study published online today in Blood offers the first evidence that such familial risks exist across the spectrum of hematologic malignancies (MM).” Second only to “Why did I getContinue reading
“Many people survive their cancers, but end up dying of cardiovascular disease (CVD). New research finds that Cardiovascular Disease risk factors may be overlooked during survivorship care” ManyContinue reading
“A concurrent study of honokiol in multiple myeloma demonstrated that honokiol killed myeloma cells from relapsed patients at doses that did not kill PBMCs…” Honokiol is cytotoxic toContinue reading
“Along with maintaining a healthy attitude, avoiding illness and infection, and exercising regularly, research shows that (MM) cancer nutrition can influence cancer progression, recurrence risk,Continue reading
Conclusion: PAd is an active salvage therapy with manageable toxicity in patients with relapsed/refractory multiple myeloma. The good news is that there is a long and growing list of conventional, FDAContinue reading
higher consumption of green tea (GTE) has been associated with a lower prevalence of cognitive impairment in older adults, less Coronary Artery Disease, ischemic stroke reduction, reduced risk of certainContinue reading
Blood Diagnostic Testing for the Layman- LabCorp blood work October 2014 From the time I was first diagnosed with multiple myeloma (MM) in January of 1994, I have learned one thing above all others. AccurateContinue reading
Chronic systemic inflammation becomes increasingly associated with risk of death, loss of cognitive function and increasing dependency Could five nutritional supplements be the proverbial “fountainContinue reading
70-80% of multiple myeloma patients will have bone involvement, with risk for skeletal-related events…Bone lesions most commonly involve the vertebra, ribs, skull, pelvic bones and femur in descendingContinue reading